Imperial Hotel, The Current Fiscal Year Net Income Revised Upward by 39%
9708 Imperial Hotel, Ltd. 【J-GAAP】
Guidance Update ReportImperial Hotel, Ltd. <9708> [TSE Std] announced a performance revision in the afternoon session on March 25th (14:00). The consolidated net income for the fiscal year ending March 2025 has been revised upward 38.9%, from the previous forecast of 1.8 billion yen to 2.5 billion yen (compared to 3.37 billion yen in the previous period), and the declining rate is expected to decrease from 46.7% to 26.0%.
Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated net income has been revised upward 45.5%, from the previous forecast of 1.54 billion yen to 2.24 billion yen (compared to 2.45 billion yen in the same period of the previous year), and the declining rate is expected to decrease from 37.1% to 8.6%.
Kabutan News
Guidance Update
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 Prev | 28,261M | 1,428M | 1,573M | 1,540M | 13.0 | 4 | Oct 30, 2024 | J-GAAP |
| Oct - Mar, 2024 New | 28,261M | 1,428M | 1,673M | 2,240M | 18.9 | 4 | Mar 25, 2025 | J-GAAP |
| Revision Rate | 0.0% | 0.0% | +6.4% | +45.5% | +45.5% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Prev | 53,000M | 1,500M | 1,850M | 1,800M | 15.2 | 6 | Jul 26, 2024 | J-GAAP |
| Mar, 2025 New | 53,000M | 1,500M | 1,950M | 2,500M | 21.1 | 6 | Mar 25, 2025 | J-GAAP |
| Revision Rate | 0.0% | 0.0% | +5.4% | +38.9% | +38.9% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
29,097M | 2,072M | 2,345M | 2,450M | 20.7 | 4 | May 10, 2024 | J-GAAP |
|
Guidance
Oct - Mar, 2024
|
28,261M | 1,428M | 1,673M | 2,240M | 18.9 | 4 | Mar 25, 2025 | J-GAAP |
| YoY | -2.9% | -31.1% | -28.7% | -8.6% | -8.6% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
43,772M | 348M | 1,652M | 1,951M | 16.5 | 4 | May 11, 2023 | J-GAAP |
|
|
53,335M | 2,839M | 3,296M | 3,377M | 28.5 | 6 | May 10, 2024 | J-GAAP |
|
Guidance
Mar, 2025
|
53,000M | 1,500M | 1,950M | 2,500M | 21.1 | 6 | Mar 25, 2025 | J-GAAP |
| YoY | -0.6% | -47.2% | -40.8% | -26.0% | -26.0% |
Related Articles
-
New Japan Chemical, The Current Fiscal Year Net Income Revised Downward by 64%
Tue Mar 25, 2025 3:40 pm JST Revision -
SD ENTERTAINMENT, Decides to Continue No Dividend Policy
Tue Mar 25, 2025 3:30 pm JST Revision -
Osaki Electric, Current Fiscal Year Dividend Revised Upward by 2 yen
Tue Mar 25, 2025 3:35 pm JST Revision -
NIPPON SANSO, The Current Fiscal Year Net Income Revised Downward to an Unexpected 9% Decrease
Tue Mar 25, 2025 3:30 pm JST Revision -
OKUWA, Last Fiscal Year Net Income Revised Downward to a Loss
Tue Mar 25, 2025 3:30 pm JST Revision -
WAKAMOTO PHARMA, The Undetermined Dividend Set at 3 yen
Tue Mar 25, 2025 12:30 pm JST Revision -
Pharmarise Holdings, Jun-Feb (Cumulative 3Q) Ordinary Profit Turns to Loss, Dec-Feb Ordinary Profit Turns to Loss
Tue Mar 25, 2025 12:00 pm JST Earnings -
The Nikkei 225 recovered to 38,000 yen level for the first time in 6 days
Tue Mar 25, 2025 9:03 am JST Market -
Nikkei 225 open on the 25th = 344 yen higher, 37,953 yen
Tue Mar 25, 2025 9:02 am JST Market -
OOMITSU, The Current Fiscal Year Ordinary Profit Revised Downward by 23%
Mon Mar 24, 2025 3:30 pm JST Earnings